191 related articles for article (PubMed ID: 18190682)
1. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway.
Webster K; Parish J; Pandya M; Stern PL; Clarke AR; Gaston K
J Biol Chem; 2000 Jan; 275(1):87-94. PubMed ID: 10617590
[TBL] [Abstract][Full Text] [Related]
3. Biomolecular Condensation of the Human Papillomavirus E2 Master Regulator with p53: Implications in Viral Replication.
Borkosky SS; Fassolari M; Campos-León K; Rossi AH; Salgueiro M; Pascuale CA; Martínez RP; Gaston K; de Prat Gay G
J Mol Biol; 2023 Aug; 435(16):167889. PubMed ID: 36402224
[TBL] [Abstract][Full Text] [Related]
4. The regulation of cell proliferation by the papillomavirus early proteins.
Hamid NA; Brown C; Gaston K
Cell Mol Life Sci; 2009 May; 66(10):1700-17. PubMed ID: 19183849
[TBL] [Abstract][Full Text] [Related]
5. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
Goodwin EC; DiMaio D
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 31 replication modes during the early phases of the viral life cycle depend on transcriptional and posttranscriptional regulation of E1 and E2 expression.
Hubert WG; Laimins LA
J Virol; 2002 Mar; 76(5):2263-73. PubMed ID: 11836404
[TBL] [Abstract][Full Text] [Related]
7. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells.
Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F
Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637
[TBL] [Abstract][Full Text] [Related]
8. Association of Human Papillomavirus 16 E2 with Rad50-Interacting Protein 1 Enhances Viral DNA Replication.
Campos-León K; Wijendra K; Siddiqa A; Pentland I; Feeney KM; Knapman A; Davies R; Androphy EJ; Parish JL
J Virol; 2017 Mar; 91(5):. PubMed ID: 28031358
[TBL] [Abstract][Full Text] [Related]
9. Roles for E1-independent replication and E6-mediated p53 degradation during low-risk and high-risk human papillomavirus genome maintenance.
Murakami I; Egawa N; Griffin H; Yin W; Kranjec C; Nakahara T; Kiyono T; Doorbar J
PLoS Pathog; 2019 May; 15(5):e1007755. PubMed ID: 31083694
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo growth inhibition of human cervical cancer cells via human papillomavirus E6/E7 mRNAs' cleavage by CRISPR/Cas13a system.
Chen Y; Jiang H; Wang T; He D; Tian R; Cui Z; Tian X; Gao Q; Ma X; Yang J; Wu J; Tan S; Xu H; Tang X; Wang Y; Yu Z; Han H; Das BC; Severinov K; Hitzeroth II; Debata PR; Xu W; Fan W; Jin Z; Cao C; Yu M; Xie W; Huang Z; Hu Z; You Z
Antiviral Res; 2020 Jun; 178():104794. PubMed ID: 32298665
[TBL] [Abstract][Full Text] [Related]
11. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
15. Productive replication of adeno-associated virus can occur in human papillomavirus type 16 (HPV-16) episome-containing keratinocytes and is augmented by the HPV-16 E2 protein.
Ogston P; Raj K; Beard P
J Virol; 2000 Apr; 74(8):3494-504. PubMed ID: 10729123
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against human papillomavirus (HPV) type 16 and 18 E2, E6 and E7 proteins in sera: correlation with presence of papillomavirus DNA.
Rosales R; López-Contreras M; Cortes RR
J Med Virol; 2001 Dec; 65(4):736-44. PubMed ID: 11745939
[TBL] [Abstract][Full Text] [Related]
17. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
[TBL] [Abstract][Full Text] [Related]
18. Dimerization of the human papillomavirus type 16 E2 N terminus results in DNA looping within the upstream regulatory region.
Hernandez-Ramon EE; Burns JE; Zhang W; Walker HF; Allen S; Antson AA; Maitland NJ
J Virol; 2008 May; 82(10):4853-61. PubMed ID: 18337573
[TBL] [Abstract][Full Text] [Related]
19. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
Fertey J; Hurst J; Straub E; Schenker A; Iftner T; Stubenrauch F
J Virol; 2011 Mar; 85(6):2918-26. PubMed ID: 21191025
[TBL] [Abstract][Full Text] [Related]
20. Interaction between the HPV-16 E2 transcriptional activator and p53.
Massimi P; Pim D; Bertoli C; Bouvard V; Banks L
Oncogene; 1999 Dec; 18(54):7748-54. PubMed ID: 10618715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
